A Preclinical Evaluation of Antimycin A as a Potential Antilung Cancer Stem Cell Agent

Drug resistance and tumor recurrence are major obstacles in treating lung cancer patients. Accumulating evidence considers lung cancer stem cells (CSCs) as the major contributor to these clinical challenges. Agents that can target lung CSCs could potentially provide a more effective treatment than t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yeh, Chi-Tai, Su, Chun-Li, Huang, Chi-Ying F., Lin, Justin Kung-Yi, Lee, Wei-Hwa, Chang, Peter M.-H., Kuo, Yu-Lun, Liu, Yu-Wen, Wang, Liang-Shun, Wu, Chih-Hsiung, Shieh, Yi-Shing, Jan, Yi-Hua, Chuang, Yung-Jen, Hsiao, Michael, Wu, Alexander T. H.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693105/
https://ncbi.nlm.nih.gov/pubmed/23840269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/910451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados